Tag Archives: Innovation

WHO’s serious reservations on Value-Based Pricing: Conflicts and Nuances

08 Jun
WHO Fair Pricing Forum Carapinha & Company

On May 10 and 11, the WHO Fair Pricing Forum met to discuss improvements to medicine pricing practices and pricing approaches that balance public health needs and incentives for pharmaceutical research and development. The Forum was established to facilitate the exchange of insights on fairer medicine pricing systems, identification of research gaps to support improvements, […]

Webinar “creating value with accessed-based marketing”: themes and reflecting on a way-forward

26 May

Carapinha & Consultants partnered with eyeforpharma to bring a webinar on creating value with accessed-based marketing. The webinar was structured around 3 core questions that eyeforpharma’s Paul Simms used to facilitate the discussion. Question 1 The first question, “In order for the industry to move forward, pharma has to prioritize” generated interesting results. 69% of respondents […]

Webinar: “Remove barriers to entry by embracing an access-based approach to marketing”

19 May
eyeforpharmabanner

We’ve joined eyeforpharma as their Strategic Partner to bring you a free webinar: “Remove barriers to entry by embracing an access-based approach to marketing” on Tuesday 26th May 2:30-3:30 pm SAST. Pharma companies in South Africa have products with compelling economic value propositions, however reimbursement constraints have limited the up-take and patient access to new therapies. But how do we […]

Research: “Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome”

15 Apr

The commonly held hypothesis that antibiotic resistance arises through (over)exposure to antibiotics is questioned in this new research. It weakens the link between resistance and antibiotic use and suggests that  “… antibiotic resistance is natural, ancient, and hard wired in the microbial pangenome.” This has implications for how we think about R&D around antibiotics and how […]

Klaus Leisinger – Novartis Foundation for Sustainable Development

15 Nov

Listen to Klaus Leisinger share his company’s perspective about corporate responsibility in the context of market and government failure. Among several points he made some included: – patents are not the only barriers to medicine access – the non-achievement of many MDGs among countries is frankly a scandal – more creative thinking is needed around […]

Propensity to patent, competition and China’s foreign patenting surge

12 Jun

Research Policy (in press) doi:10.1016/j.respol.2010.04.006 Albert Guangzhou Hu Foreign applications for Chinese patents have been growing by over 30% a year. This paper explores two hypotheses in explaining the foreign patenting surge in China: market covering and competitive threat. With foreign companies more deeply engaged with the Chinese economy, returns from protecting their intellectual property […]

Reinventing Technology Assessment for the 21st Century

13 May

A new report from the Science and Technology Innovation Program at the Woodrow Wilson International Center for Scholars defines the criteria for a new technology assessment function in the United States. The report, Reinventing Technology Assessment: A 21st Century Model, emphasizes the need to incorporate citizen-participation methods to complement expert analysis. Government policymakers, businesses, non-governmental […]

Nanotechnology, Synthetic Biology, & Public Opinion

13 May

Previous posts addressed both nanovaccines and DNA robots and they hinted at public opinion concerning nanotechnology and synthetic biology. What is the public’s opinion of these emerging technologies? A research report by the “Project on Emerging Nanotechnologies”, Nanotechnology, Synthetic Biology, & Public Opinion answers this question from the perspective of the United States. The key […]

New DNA Robots Strut Their Tiny Stuff.

13 May

DNA robots are promising products of innovation mostly due to significant research and development investment. They move in response to chemical reactions and operate as nano-factories that may help deliver medicine to difficult-to-reach sites in the body, e.g.: tumours, etc. DNA robots are at the forefront of interdisciplinary research combining synthetic chemistry, enzymology, structural nanotechnology […]

Carapinha Logo